Johnson & Johnson (JNJ) stock
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$272.70−6.00 (-2.15%)
Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%
Johnson & Johnson pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Johnson & Johnson's pe ratio was 42.6× on Nov 11, 2026, against 20.0× a year earlier. Over the last 5 years it ranged from 9.6× to 42.6×, with a median of 23.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 42.6× | +22.6 |
| 2025 | Dec 31, 2025 | 20.0× | −3.9 |
| 2024 | Dec 31, 2024 | 23.9× | +12.3 |
| 2023 | Dec 29, 2023 | 11.6× | −13.0 |
| 2022 | Dec 30, 2022 | 24.6× | −1.0 |
| 2021 | Dec 31, 2021 | 25.6× | +0.8 |
| 2020 | Dec 31, 2020 | 24.7× | −3.0 |
| 2019 | Dec 31, 2019 | 27.8× | −230.3 |
| 2018 | Dec 31, 2018 | 258.1× | +233.8 |
| 2017 | Dec 29, 2017 | 24.3× | +4.0 |
| 2016 | Dec 30, 2016 | 20.2× | +0.6 |
| 2015 | Dec 31, 2015 | 19.6× | +2.3 |
| 2014 | Dec 31, 2014 | 17.3× | −3.0 |
| 2013 | Dec 31, 2013 | 20.4× | −2.7 |
| 2012 | Dec 31, 2012 | 23.1× | +9.3 |
| 2011 | Dec 30, 2011 | 13.7× | +0.9 |
| 2010 | Dec 31, 2010 | 12.8× | −3.1 |
| 2009 | Jan 30, 2009 | 15.9× | – |
See a number that looks wrong?